Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MTD
BUYMettler-Toledo International Inc. · Healthcare · Switzerland · $26.8B · Avg Vol: $266M/d
COMPANY DESCRIPTION
Mettler-Toledo International Inc. is a global leader in precision instruments, providing weighing, analytical, and inspection solutions for laboratories, industrial manufacturing, and food retail applications. The company maintains its market leadership through continuous innovation, high-quality products essential for critical processes, and a strong global sales and service infrastructure that creates high customer switching costs.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.9B | 3.8B | 3.9B | 4.0B | 0.9% | 4.1B | 4.2B | 4.4B | 4.9% |
| EPS | 38.79 | 36.10 | 40.67 | 42.17 | 2.8% | 41.40 | 46.06 | 50.61 | 9.5% |
| Shares | 22.1M | 21.5M | 20.9M | 20.4M | -8.0% | 20.2M | — | — | — |
| Debt | 2.0B | 2.1B | 2.0B | 2.2B | 2.2% | 2.2B | — | — | — |
| Equity | 24.8M | -149.9M | -126.9M | -23.6M | — | — | — | — | — |
| Op CF | 859.1M | 965.9M | 968.3M | 955.8M | 3.6% | 901.1M | — | — | — |
| Inv CF | -139.4M | -131.7M | -119.5M | -193.9M | — | — | — | — | — |
| Fin CF | -716.0M | -859.6M | -856.0M | -755.2M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MTD are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MTD | Mettler-Toledo International Inc.(you) | $26.8B | 79 | BUY |
| LONN.SW | Lonza Group AG | $46.1B | 44 | HOLD |
| 6160.HK | BeOne Medicines AG | $28.5B | 88 | STRONG BUY |
| SOON.SW | Sonova Holding AG | $14.3B | 78 | BUY |
| STMN.SW | Straumann Holding AG | $20.9B | 68 | BUY |
| GALD.SW | GALDERMA GROUP N | $49.5B | 69 | BUY |
| SDZ.SW | Sandoz Group AG | $36.5B | 60 | HOLD |
| ALC | Alcon Inc. | $33.1B | 55 | HOLD |
| YPSN.SW | YPSOMED HLDG | $5.8B | 75 | BUY |
| 0QLQ.L | Ypsomed Holding AG | $4.8B | 71 | BUY |
Peer medians: ROE 12.0% · P/E 24.3x · Gross margin 47.9%